殷勇，博士，副教授，博士/硕士研究生导师。研究方向为天然产物的结构修饰与改造，以及基于活性天然产物骨架的小分子抗肿瘤药物的发现与研究。作为课题负责人目前主持国家自然科学青年科学基金、国家自然科学面上项目、中央高校基本科研业务费自然科学重点项目等基金项目。作为重要成员参与了国家重大新药创制、自然科学基金等国家级和省部级基金多项。以第一作者或通讯作者在Nature Communications, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry等期刊发表SCI论文20余篇。

本科生：《天然药物化学》及《天然药物化学实验》、《波谱解析》

研究生：《复杂天然产物波谱解析》、《药物结构解析》。

天然产物的结构修饰与改造，以及基于活性天然产物骨架的小分子抗肿瘤药物的发现与研究。

1. He XY, Liu CY, Ding XY, Lin Q, Leng JF, Xiao CM, Zang X, Wang MY, Yin Y, Kong LY, Xia YZ. KY216-tubulin complex captures VASH2 to inhibit NSCLC metastasis. Nat Commun. 2025,17(1):191.

2. Leng J, Zhao Y, Zhao S, Xie S, Sheng P, Zhu L, Zhang M, Chen T, Kong L, Yin Y. Discovery of Novel Isoquinoline Analogues as Dual Tubulin Polymerization/V-ATPase Inhibitors with Immunogenic Cell Death Induction. J Med Chem. 2024,67(4):3144-3166.

3. Chen T, Leng J, Tan J, Zhao Y, Xie S, Zhao S, Yan X, Zhu L, Luo J, Kong L, Yin Y. Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer. J Med Chem. 2023,66(14):10036-10059.

4. Leng J, Zhao Y, Sheng P, Xia Y, Chen T, Zhao S, Xie S, Yan X, Wang X, Yin Y, Kong L. Discovery of Novel N-Heterocyclic-Fused Deoxypodophyllotoxin Analogues as Tubulin Polymerization Inhibitors Targeting the Colchicine-Binding Site for Cancer Treatment. J Med Chem. 2022,65(24):16774-16800.

5. Ning M, Zhao B, Cao T, Wu J, Zhang C, Kong L, Luo J, Yin Y. Discovery of novel benzylaniline derivatives containing chloroacetamide as GPX4 inhibitors with potential efficacy in triple-negative breast cancer. Eur J Med Chem. 2025,300:118189.